Literature DB >> 18438954

Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).

F Haller1, C Löbke, M Ruschhaupt, S Cameron, H-J Schulten, S Schwager, A von Heydebreck, B Gunawan, C Langer, G Ramadori, H Sültmann, A Poustka, U Korf, L Füzesi.   

Abstract

Loss of chromosome 9p is a reliable predictor of malignant behaviour in gastrointestinal stromal tumours (GISTs). p16INK4A located at 9p21 inhibits the CDK4/6/cyclin D complex from phosphorylating RB. Phosphorylation of RB through CDK4/6/cyclin D in early G(1) phase frees the transcription factor E2F1 from RB and enables mRNA transcription of genes essential for G(1)/S phase transition. This study aims to determine the impact of 9p loss on mRNA and protein expression of p16INK4A and further key cell cycle regulators in the different phases of the cell cycle. Sixty primary GISTs previously characterized for 9p loss by comparative genomic hybridization were analysed for mRNA expression of p16INK4A, p15INK4B, CDK4, CDK6, cyclin D, p21CIP1p27KIP1, CDK2, cyclin E, cyclin B, RB and E2F1, using quantitative RT-PCR. The protein expression of CDK6, CDK2, p21CIP1, p27KIP1 and phosphorylated RB (S807/S811) was evaluated using protein arrays as a novel and highly sensitive platform for profiling of protein abundance and protein phosphorylation. In parallel, the nuclear percentages of immunohistochemical staining for p16INK4A, cyclin D, E2F1 and RB were quantified on a tissue microarray. GISTs with 9p loss had significantly higher proliferation rates, higher metastatic behaviour and shorter disease-free survival. On the molecular level, GISTs with 9p loss had a significantly reduced mRNA as well as nuclear protein expression of p16INK4A. RB was significantly more phosphorylated in these tumours, together with increased mRNA expression and nuclear staining for E2F1. Furthermore, GISTs with 9p loss had up-regulation of the late G1/S phase promoters CDK2 and cyclin E. We conclude that loss of 9p accompanied by early G1 phase inhibitor p16(INK4A) down-regulation in GISTs facilitates phosphorylation of RB, enabling E2F1-dependent transcription of genes essential for late G1/S phase transition. This study provides a possible basis for the accelerated proliferation and particularly malignant behaviour in GISTs with 9p loss. Copyright (c) 2008 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438954     DOI: 10.1002/path.2352

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  [Multilayer analysis of signal transduction and cell cycle control in GIST. Identifying new interaction partners with differential regulation].

Authors:  F Haller; D J Zhang; C Löbke; A von Heydebreck; U Korf; L Füzesi; O Sahin
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

2.  [Molecular biological evaluation of prognostic parameters in GIST. Development of an integrative model of tumor progression].

Authors:  F Haller
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

3.  Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor.

Authors:  Yun Zhang; Hui Cao; Ming Wang; Wen-Yi Zhao; Zhi-Yong Shen; Dan-Ping Shen; Xing-Zhi Ni; Zhi-Yong Wu; Yan-Ying Shen; Yan-Yan Song
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

4.  [Identification and validation of clinically relevant molecular alterations in prostate cancer].

Authors:  T Schlomm; H Sültmann; J Köllermann
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

5.  [Identification and validation of clinically relevant molecular alterations in prostate cancer].

Authors:  T Schlomm; H Sültmann; J Köllermann
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

6.  Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).

Authors:  Silke Cameron; Marieke Gieselmann; Martina Blaschke; Giuliano Ramadori; Laszlo Füzesi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

7.  Aberrant promoter methylation of p15 (INK⁴b) and p16 (INK⁴a) genes may contribute to the pathogenesis of multiple myeloma: a meta-analysis.

Authors:  Xuan Wang; Yan-Bin Zhu; Hai-Peng Cui; Ting-Ting Yu
Journal:  Tumour Biol       Date:  2014-06-08

8.  Novel mouse model recapitulates genome and transcriptome alterations in human colorectal carcinomas.

Authors:  Nicole E McNeil; Hesed M Padilla-Nash; Floryne O Buishand; Yue Hue; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2016-11-01       Impact factor: 5.006

9.  Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.

Authors:  Jan C Brase; Heiko Mannsperger; Holger Fröhlich; Stephan Gade; Christian Schmidt; Stefan Wiemann; Tim Beissbarth; Thorsten Schlomm; Holger Sültmann; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-06-22       Impact factor: 2.480

10.  Down-regulation of miR-106b suppresses the growth of human glioma cells.

Authors:  Anling Zhang; Jianwei Hao; Kun Wang; Qiang Huang; Kai Yu; Chunsheng Kang; Guangxiu Wang; Zhifan Jia; Lei Han; Peiyu Pu
Journal:  J Neurooncol       Date:  2013-02-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.